Cargando…
Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time
Treatment with broadly neutralizing antibodies (bNAbs) has proven effective against HIV-1 infections in humanized mice, non-human primates, and humans. Due to the high mutation rate of HIV-1, resistance testing of the patient’s viral strains to the bNAbs is still inevitable. So far, bNAb resistance...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669501/ https://www.ncbi.nlm.nih.gov/pubmed/29065122 http://dx.doi.org/10.1371/journal.pcbi.1005789 |